Verano Holdings (VRNO) Non Operating Income (2021 - 2026)

Verano Holdings' (VRNO) quarterly Non Operating Income came in at -$12.3 million in Q1 2026, down 34.29% year-on-year from -$18.7 million in Q1 2025, and down 29.0% on a QoQ basis from -$9.5 million in Q4 2025.

Verano Holdings (VRNO) Non Operating Income (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Non Operating Income data on file, last reported at -$12.3 million in Q1 2026.

  • On a quarterly basis, Non Operating Income fell 34.29% year-over-year to -$12.3 million in Q1 2026; TTM through Mar 2026 was -$60.7 million, a 21.7% decrease from a year earlier, with the FY2025 full-year figure at -$53.6 million, up 2.14% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$12.3 million, down from -$9.5 million in the prior quarter.
  • Over the last five years, Non Operating Income for VRNO reached as high as $3.5 million in Q2 2022 and fell as low as -$24.7 million in Q3 2025.
  • Historically, Non Operating Income has averaged -$12.8 million across 5 years, with a median of -$13.9 million in 2024.
  • Across the five-year window, Non Operating Income soared 159.19% in 2022 and tumbled 545.66% in 2023, its largest moves.
  • Year by year, Non Operating Income stood at -$15.3 million in 2022, then increased by 22.46% to -$11.9 million in 2023, then fell by 6.18% to -$12.6 million in 2024, then increased by 24.48% to -$9.5 million in 2025, then dropped by 29.0% to -$12.3 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were -$12.3 million in Q1 2026, -$9.5 million in Q4 2025, and -$24.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -12.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.31 Mn
Dec 31, 2025 -9.54 Mn
Sep 30, 2025 -24.67 Mn
Jun 30, 2025 -14.21 Mn
Mar 31, 2025 -9.17 Mn
Dec 31, 2024 -12.64 Mn
Sep 30, 2024 -13.86 Mn
Jun 30, 2024 -14.24 Mn
Mar 31, 2024 -15.11 Mn
Dec 31, 2023 -11.90 Mn
Sep 30, 2023 -15.17 Mn
Jun 30, 2023 -15.81 Mn
Mar 31, 2023 -15.91 Mn
Dec 31, 2022 -15.35 Mn
Sep 30, 2022 -10.69 Mn
Jun 30, 2022 3.55 Mn
Mar 31, 2022 -10.67 Mn
Dec 31, 2021 -7.75 Mn
Sep 30, 2021 -8.11 Mn
Jun 30, 2021 -5.99 Mn